Emerging Clinical Applications For Cannabis & Cannabinoids - Alzheimer's Disease

Thu, 01/15/2009 - 19:48 — thcf

Alzheimer’s disease (AD) is a neurological disorder of unknown origin that is characterized by a progressive loss of memory and learned behavior. Patients with Alzheimer’s are also likely to experience depression, agitation, and appetite loss, among other symptoms. Over 4.5 million Americans are estimated to be afflicted with the disease. No approved treatments or medications are available to stop the progression of AD, and few pharmaceuticals have been FDA-approved to treat symptoms of the disease.

A review of the recent scientific literature indicates that cannabinoid therapy may provide symptomatic relief to patients afflicted with AD while also moderating the progression of the disease.

Support NORML!

Source: http://norml.org/index.cfm?Group_ID=7003

Bookmark/Search this post with:

Printer-friendly version
Login or register to post comments

Cannabis Common Sense - Youtube

MAP - Medicinal Cannabis

9 Days & Counting

Michigan Medical Marijuana Association

NORML Daily News

Salem-News Medical Marijuana

Sensible Colorado

Our physicians help qualified patients obtain a state permit to legally possess, use and grow medical marijuana. Our clinics help patients learn to cultivate cannabis and teach the about alternatives to smoking, such as vaporization and making cannabis foods and extracts with oil, butter, alcohol and glycerine.

THCF has produced almost 500 episodes of our live weekly TV show, Cannabis Common Sense. Our show is on cable television in Oregon, Washington, California, Colorado and Michigan, and is available, now, on demand on our websites. THCF also purchases advertising to educate the public and tell the truth about hemp and cannabis.

THCF has helped 100,000 patients obtain their state's permit to legally possess, use and grow marijuana.